Cargando…

Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report

In an intestinal transplant patient under triple immunosuppression therapy with tacrolimus levels >10 ng/L, a 2‐day oral immunoglobulin therapy given as treatment for chronic norovirus infection was temporally closely associated with the development of severe steroid‐resistant acute graft rejecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Åberg, Fredrik, Savikko, Johanna, Anttila, Veli‐Jukka, Mäkisalo, Heikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028366/
https://www.ncbi.nlm.nih.gov/pubmed/29988627
http://dx.doi.org/10.1002/ccr3.1493
_version_ 1783336745473933312
author Åberg, Fredrik
Savikko, Johanna
Anttila, Veli‐Jukka
Mäkisalo, Heikki
author_facet Åberg, Fredrik
Savikko, Johanna
Anttila, Veli‐Jukka
Mäkisalo, Heikki
author_sort Åberg, Fredrik
collection PubMed
description In an intestinal transplant patient under triple immunosuppression therapy with tacrolimus levels >10 ng/L, a 2‐day oral immunoglobulin therapy given as treatment for chronic norovirus infection was temporally closely associated with the development of severe steroid‐resistant acute graft rejection, thus suggesting that oral immunoglobulin might be able to promote a rejection response.
format Online
Article
Text
id pubmed-6028366
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60283662018-07-09 Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report Åberg, Fredrik Savikko, Johanna Anttila, Veli‐Jukka Mäkisalo, Heikki Clin Case Rep Case Reports In an intestinal transplant patient under triple immunosuppression therapy with tacrolimus levels >10 ng/L, a 2‐day oral immunoglobulin therapy given as treatment for chronic norovirus infection was temporally closely associated with the development of severe steroid‐resistant acute graft rejection, thus suggesting that oral immunoglobulin might be able to promote a rejection response. John Wiley and Sons Inc. 2018-05-11 /pmc/articles/PMC6028366/ /pubmed/29988627 http://dx.doi.org/10.1002/ccr3.1493 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Åberg, Fredrik
Savikko, Johanna
Anttila, Veli‐Jukka
Mäkisalo, Heikki
Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
title Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
title_full Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
title_fullStr Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
title_full_unstemmed Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
title_short Severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
title_sort severe allograft rejection in an intestinal transplant patient following oral immunoglobulin treatment for chronic norovirus infection: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028366/
https://www.ncbi.nlm.nih.gov/pubmed/29988627
http://dx.doi.org/10.1002/ccr3.1493
work_keys_str_mv AT abergfredrik severeallograftrejectioninanintestinaltransplantpatientfollowingoralimmunoglobulintreatmentforchronicnorovirusinfectionacasereport
AT savikkojohanna severeallograftrejectioninanintestinaltransplantpatientfollowingoralimmunoglobulintreatmentforchronicnorovirusinfectionacasereport
AT anttilavelijukka severeallograftrejectioninanintestinaltransplantpatientfollowingoralimmunoglobulintreatmentforchronicnorovirusinfectionacasereport
AT makisaloheikki severeallograftrejectioninanintestinaltransplantpatientfollowingoralimmunoglobulintreatmentforchronicnorovirusinfectionacasereport